Novità

36° Congresso Nazionale SISA - Premiate le migliori presentazioni

SPAZIO GIOVANI: Alessia Caviccholi

THE SPECTRUM OF FATTY LIVER DISEASE AND THE ROLE OF GENETIC, METABOLIC AND LIFESTYLE FACTORS ASSOCIATED WITH ITS SEVERITY IN HETEROZYGOUS APOLIPOPROTEIN B-RELATED FAMILIAL HYPOBETALIPOPROTEINEMIA
A. Cavicchioli, M. D’Avino, S. Lugari, C. Felicani, P. Andreone, F. Carubbi, F. Nascimbeni

SPAZIO GIOVANI: Samantha Maurotti

A NUTRACEUTICAL CONTAINING BERGAMOT CITRUS AND ARTICHOKE IMPROVES LIVER STEATOSIS IN OBESE ADULTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
S. Maurotti, A. Mirarchi, G. Boragina, M.G. Settino, N. Geirola, G. Marafioti, M. Rago, Y. Ferro, A. Sciacqua, A. Pujia, T. Montalcini

SPAZIO GIOVANI: Elena Olmastroni

LIPOPROTEIN(A) DOES NOT HAVE A CLINICAL ARTERIAL OR VENOUS PROTHROMBOTIC EFFECT
E. Olmastroni, F. Galimberti, J.L. Katzmann, U. Laufs, M.S. Sabatine, A.L. Catapano, B.A. Ference

COMUNICAZIONI ORALI: Simone Bini

ANGPTL3 AND PCSK9 DIRECTLY INTERACT AND COORDINATE THE REGULATION OF CELLULAR METABOLISM IN VITRO
S. Bini, V. Pecce, L. D’Erasmo, I. Minicocci, A. Di Costanzo, F. Tambaro, S. Covino, D. Tramontano, M. Arca

COMUNICAZIONI ORALI: Federica Galimberti

THE LIFETIME RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE DOES NOT VARY BASED ON GENETICALLY DETERMINED OR CLINICALLY MEASURED LIPOPROTEIN(A) LEVELS
F. Galimberti, E. Olmastroni, A.L. Catapano, B.A. Ference

COMUNICAZIONI ORALI: Marta Gazzotti

EVIDENCE FOR THE REFINEMENT OF THE DIAGNOSTIC APPROACH IN CHILDREN AND ADOLESCENTS AFFECTED BY FAMILIAL HYPERCHOLESTEROLEMIA: DATA FROM THE LIPIGEN STUDY
M. Gazzotti, E. Olmastroni, C. Pederiva, M.E. Capra, A.L. Catapano, M. Casula, on behalf of the LIPIGEN study and the LIPIGEN paediatric group

SESSIONI POSTER: Maria Elena Capra

A SMALL LIPOPROTEIN THAT CAN MAKE THE DIFFERENCE: THE ROLE OF LIPOPROTEIN(A) IN CARDIOVASCULAR RISK STRATIFICATION AND REVERSE SCREENING IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLAEMIA
M.E. Capra, G. Biasucci

SESSIONI POSTER: Francesco Spannella

PLASMA LEVELS OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 ARE INVERSELY ASSOCIATED WITH N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE IN OLDER POPULATION
F. Spannella, F. Giulietti, R. Galeazzi, A. Passarelli, S. Re, C. Di Pentima, M. Allevi, S. Sarnari, P. Magni, R. Sarzani

SESSIONI POSTER: Arianna Toscano

PCSK9 PLASMA LEVELS ARE ASSOCIATED WITH MECHANICAL VASCULAR IMPAIRMENT IN FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS WITHOUT A HISTORY OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: RESULTS OF SIX-MONTH ADD-ON PCSK9 INHIBITOR THERAPY
A. Toscano, M. Cinquegrani, M. Scuruchi, A. Di Pino, S. Piro, V. Ferrara, C. Morace, A. Lo Gullo, E. Imbalzano, F. Purrello, G. Squadrito, R. Scicali, and G. Mandraffino

*Nota: non è stato possibile assegnare il premio a Maria Giovanna Lupo per ineleggibilità dovuta alla non presenza al congresso.